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Abstract
Introduction: Improving access to HIV testing is a key priority in scaling up HIV treatment and prevention services. Home-
based voluntary counselling and testing (HBT) as an approach to delivering wide-scale HIV testing is explored here.
Methods and Findings: We conducted a systematic review and random-effects meta-analysis of studies published between
1 January 2000 and 24 September 2012 that reported on uptake of HBT in sub-Saharan Africa, to assess the proportion of
individuals accepting HBT and receiving their test result. Our initial search yielded 1,199 articles; 114 were reviewed as full-
text articles, and 19 publications involving 21 studies (n= 524,867 individuals offered HBT) were included for final review
and meta-analysis. The studies came from five countries: Uganda, Malawi, Kenya, South Africa, and Zambia. The
proportion of people who accepted HBT (n= 474,377) ranged from 58.1% to 99.8%, with a pooled proportion of 83.3% (95%
CI: 80.4%–86.1%). Heterogeneity was high (t2 = 0.11). Sixteen studies reported on the number of people who received the
result of HBT (n= 432,835). The proportion of individuals receiving their results out of all those offered testing ranged from
24.9% to 99.7%, with a pooled proportion of 76.7% (95% CI: 73.4%–80.0%) (t2 = 0.12). HIV prevalence ranged from 2.9% to
36.5%. New diagnosis of HIV following HBT ranged from 40% to 79% of those testing positive. Forty-eight percent of the
individuals offered testing were men, and they were just as likely to accept HBT as women (pooled odds ratio = 0.84; 95% CI:
0.56–1.26) (t2 = 0.33). The proportion of individuals previously tested for HIV among those offered a test ranged from 5% to
66%. Studies in which ,30% of individuals had been previously tested, local HIV prevalence was ,10%, incentives were
provided, or HBT was offered to household members of HIV-positive individuals showed higher uptake of testing. No
evidence was reported of negative consequences of HBT.
Conclusions: HBT could substantially increase awareness of HIV status in previously undiagnosed individuals in sub-Saharan
Africa, with over three-quarters of the studies in this review reporting .70% uptake. It could be a valuable tool for
treatment and prevention efforts.
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Introduction
Testing for HIV is the first step in the cascade of care for HIV-
positive individuals who need treatment. Knowledge of HIV status
is also an important part of HIV prevention, for both HIV-
negative and HIV-positive individuals, and developing innovative
means to increase uptake of testing has recently been identified as
an international policy priority [1–4]. Despite some progress,
knowledge of HIV status remains low in sub-Saharan Africa (SSA),
where HIV prevalence is highest [5]. National population surveys
in six sub-Saharan African countries found that amongst
participants living with HIV there was a wide range in the
proportion of respondents aware of their status (from 31% in
Congo to 69% in Kenya) [5]. Men have consistently been shown
to be less likely to have been tested for HIV than women [5,6].
Out-of-facility approaches to offering testing in the community
[7,8] and the workplace [9,10] are means of bringing access to
testing closer to clients. By removing distance as a barrier, these
methods could be complementary means to scale up HIV testing
[11]. Home-based voluntary counselling and testing (HBT) has
been suggested as an effective out-of-facility approach for
identifying HIV-infected people at an earlier stage of their disease
and for enrolling them into care and treatment in a timely manner
[12–14]. The World Health Organization has recently published a
handbook to guide service providers and policy makers in
delivering HBT [14]. HBT may reach individuals that community
venue-based testing and workplace testing do not because it does
not require clients to come forward [14]. In HBT it is the test
provider who approaches the client, regardless of his/her
perceived risk of having HIV [15]. However, there is uncertainty
about HBT and concern that it may be poorly accepted or even
harmful, partly owing to the enduring climate of stigma and
discrimination around HIV/AIDS in many settings [16,17].
We carried out a systematic review and meta-analysis of the
available evidence regarding the acceptability of HBT in SSA, and
assessed a number of potential determinants of uptake and
programme success.
Methods
We conducted this systematic review and meta-analysis based
on a pre-defined search protocol (Text S2) that conformed to the
criteria set out by the Meta-Analysis of Observational Studies in
Epidemiology (MOOSE) group [18] and was in accordance with
the PRISMA statement (Text S1). The specific objectives of the
study were to summarise the following proportions: ‘‘accepted’’ (or
uptake), defined as the proportion of all individuals offered HBT
who accepted and had an HIV test performed at home;
‘‘received’’, defined as the proportion of all individuals who
accepted a home-based HIV test who subsequently obtained the
result of the test; and ‘‘overall’’, defined as the proportion of
individuals who received a test result among all those offered HBT
(including refusals). We also planned sub-group analyses as
outlined below.
Search Strategy
We aimed to summarise studies that described uptake of HIV
testing provided at home in SSA. We screened studies published
between 1 January 2000 (the onset of programmes providing
antiretroviral therapy in SSA) and 24 September 2012. The
following study designs were permitted: randomised controlled
trials, observational cohort studies, cross-sectional surveys, and
programme evaluations. Any study that described an interven-
tion to provide HIV testing at home and reported proportions
accepting HIV testing out of all individuals offered a home-based
HIV test was included. Where acceptance of testing was
reported, it was assumed that testing was performed unless
stated otherwise.
To avoid duplication we excluded reports that pooled data from
previously published studies, and where there was substantial
overlap of study participants, we included the study with the most
complete information. No language or age restriction was applied
to the literature search. To identify studies for this systematic
review, we searched the online databases PubMed, Embase, and
Global Health (Ovid) and manually searched the bibliographies of
relevant articles. We included only peer-reviewed journal articles;
conference abstracts were excluded. Anticipating overlap between
studies reporting HBT and other community-based strategies, we
developed a broad compound search strategy that combined terms
for ‘‘HIV’’, ‘‘voluntary counselling and testing’’, ‘‘home based’’,
‘‘mobile’’, ‘‘community’’, ‘‘workplace’’, ‘‘couples’’, and ‘‘self’’. We
then combined these terms with the individual names of countries
in SSA (Text S2). Finally, we excluded all studies that did not
report home-based delivery of HIV testing.
Eligibility of abstracts and journal articles was determined by
one investigator (K. S.) and verified by a second researcher (R. V.
d. B.). Two investigators (K. S. and R. V. d. B.) then
independently extracted data on study characteristics and
outcomes using a standardised form. Any disagreements regarding
eligibility or outcome data were resolved by a third investigator (N.
F.). The rigour of study processes and research methods was
examined using pre-defined criteria, but studies were not excluded
for quality reasons.
Data Synthesis and Analysis
We calculated the proportion of people who accepted HIV
testing at home, and the proportion who received their test result
out of those (i) who were offered and (ii) who accepted testing.
The variance of raw proportions was stabilised using a Freeman–
Tukey arcsine square-root transformation, and proportions were
then pooled using a DerSimonian–Laird random-effects model
[19–21]. Pooled odds ratios were calculated for proportions
stratified by gender, also using a random-effects model. We
report the I2 statistic to assess the proportion of variability due to
between-study heterogeneity, but as this estimate is known to
increase as the number of participants contributing to the meta-
analysis increases [21], we also report t2 as a measure of between-
study variance (reported on the arcsine square-root scale). We
explored potential sources of heterogeneity through univariate
sub-group analysis to determine the potential influence of the
following covariates: HIV prevalence (,10% versus $10%),
study period (before 2005 versus 2005 or later), incentives
provided (yes versus no), sensitisation campaigns done (yes versus
no), and study setting (urban versus rural). We further explored
the potential influence of type of test (point-of-care testing with
immediate result versus testing without immediate provision of
result). Finally, sub-group analyses were done to assess the
potential influence of the proportion of individuals in the studies
who had been previously tested (arbitrarily divided into two
categories, ,30% versus $30%), and of studies that targeted
HBT to household members of index HIV-positive individuals.
We opted for sub-group analyses over meta-regression because of
the limited number of studies and the dichotomous nature of
most variables. All analyses were conducted using Stata version
12.0 (Stata Corp).
A Meta-Analysis of Home-Based HIV Testing
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Results
Characteristics of Included Studies
Our initial search yielded 1,199 articles, of which 114 were
reviewed as full-text articles and 19 were included in the meta-
analysis (Figure 1) after excluding four studies with clearly
overlapping study populations [22–25]. Two included publications
presented data of two sub-studies: the first article included data
from two surveys done in two separate time periods [26]; the
second article reported different subsets of individuals (residents
and migrants) [27]. As such, we present data and results of
analyses based on these 21 studies from the 19 articles. The studies
were from five countries: Uganda [28–35], Malawi [26,36–39],
Kenya [40,41], South Africa [27,42], and Zambia [43], and were
carried out between 1999 and 2010. Most studies focused on
adults (defined either as aged $18 y or, more commonly, $15 y),
while seven studies also included children [28,30,32,33,35,40,42].
Regional HIV prevalence (reported by the authors for the study
areas or obtained from Joint United Nations Programme on HIV/
AIDS contemporaneous national data) ranged from 4.4% to 22%
(Table 1). Testing was generally provided by counsellors; one study
included laboratory assistants in the testing teams [32], and two
utilised nurses [31,42]. One study employed self-testing with
counsellor supervision [36]. HIV prevalence amongst those tested
ranged from 2.9% to 36.5%.
Table 2 summarises the factors that potentially influence the
rigour of the studies and shows that there was wide variation in
standards of implementation and research. For instance, 11 studies
did not describe their sampling strategy, though none showed
evidence of selective outcome reporting. Six studies did not
automatically provide results to clients upon testing them for HIV
(HIV prevalence surveys), and three studies did not report whether
return visits were made when individuals were not at home. One
study reported giving advice for repeat testing after 3 mo to people
testing HIV-negative [26]. Two other studies reported giving HIV
prevention counselling to HIV-negative individuals [31,40]. Ten
studies reported some means of linkage to care, mostly advising
HIV-positive patients to seek care at the nearest health facility
[26,28,30–32,36,39–41,44]. One study presented data on the
proportion of individuals linked into care upon testing HIV-
positive (n=11,359), with 97% of them initiating co-trimoxazole
and 11% commencing antiretroviral therapy [32]. Two studies
presented information on the clinical condition of individuals
found to be HIV-positive [30,32]. Following HBT, the majority of
HIV-positive individuals who had CD4 counts assessed had
measures above treatment initiation thresholds applicable at the
time (.200 cells/mm3) [30,32].
Proportion of Individuals Accepting Testing and
Receiving Results
A total of 524,867 people were offered HBT across the 21
studies, which ranged in size from 216 [36] to 282,857 [32]
people. Twelve studies disaggregated data on offer of HBT by
gender, with 180,942 men and 198,042 women offered testing
overall [27–33,36–38,43]. The proportion of those offered testing
who were men (in the studies that reported on gender) ranged
from 22% to 49%, with an overall proportion of 47%.
Across all 21 studies the proportion of people who accepted
HBT ranged from 58.1% (95% CI: 57.5%–58.8%) to 99.7% (95%
CI: 99.7%–99.8%), with a pooled proportion of 83.3% (95% CI:
80.4%–86.1%) accepting to be tested (n=474,377) (Figure 2).
Heterogeneity was high (t2 = 0.11). In studies that reported on
acceptance of HBT by gender (eight studies) [22,27,31–33,38,43],
men were as likely as women to accept testing (78.5% [95% CI:
71.1%–86.0%] versus 81.5% [95% CI: 72.9%–90.1%]). The
pooled odds ratio of men accepting HBT was 0.84 (95% CI: 0.56–
1.26) compared to women (t2 = 0.33). Studies that offered targeted
HBT to household members of index HIV-positive individuals
[28,33] achieved higher proportions of uptake than the other
studies: 94.0% (95% CI: 82.4%–100%) versus 80.6% (95% CI:
77.2%–84.0%) (p,0.001).
Sixteen studies reported on the number of people who received
the result of HBT (n=432,835) [26,28–32,34–38,40,41,43,44].
The proportion receiving a result out of those who accepted testing
ranged from 36.8% (95% CI: 33.9%–39.7%) [34] to 100% (95%
CI: 100%–100%) [40], with a pooled proportion of 99.6% (95%
CI: 99.5%–99.6%) receiving their result (t2 = 0.12) (Figure S1).
The proportion of individuals receiving their results overall (out of
all those offered testing) ranged from 24.9% (95% CI: 22.8%–
27.1%) to 99.7% (95% CI: 99.7%–99.8%), with a pooled
proportion of 76.7% (95%CI: 73.4%–80.0%) (t2 = 0.12) (Figure 3).
Eleven studies (n=456,283) reported on the number of
individuals offered testing who had already been previously tested
(n=78,527) [26,29–33,36–38,40,44]; three studies reported on the
number tested within the last 12 mo [26,31,34]. However, authors
did not report the definition of ‘‘previously tested’’ and whether it
included all those who had had a test or was limited to those who
received their result and became aware of their HIV status. The
proportion of individuals previously tested ranged from 5% to
66% overall (11 studies); 22%–50% were previously tested within
the last 12 mo (three studies). Studies in which ,30% of people
had previously been tested (five studies, n=436,618)
[30,32,33,37,40] on average reported a higher frequency of test
acceptance than studies in which $30% of people had been
previously tested (six studies, n=19,665) [26,29,31,36,38,44]
(92.1% [95% CI: 87.8%–96.4%] versus 82.1% [95% CI:
75.6%–88.6%], p=0.01).
One study explicitly reported excluding individuals already
known to be HIV-positive [40]. Angotti et al. [26] reported that
68% (11/72) of known HIV-positive individuals accepted HBT
versus 90% (1,430/1,588) of individuals who were HIV-negative
when they previously tested. Choko et al. [36] invited participants
to partake in oral self-testing even if they knew they were HIV-
positive (19 HIV-positive out of 175 previously tested individuals).
Amongst individuals previously tested for HIV who accepted HBT
in the study by Matovu et al. [22] 10% (n=350/3,362) were
already known to be sero-positive. Of those testing HIV-positive
through HBT, 40%–79% had not previously been diagnosed (five
studies) [22,31,33,36,40] (this information for the study by Matovu
et al. was obtained from a second publication in 2005 [22] rather
than the 2002 publication [29] about the same study that was
included in this review).
Table S1 summarises the individual-level factors associated with
uptake of testing, and shows a wide variation in findings across the
studies that reported on this [28,29,31,32,37,38].
Potential Harm and Cost Considerations
Eight of the articles we examined acknowledged the potential
for harm from testing for HIV [28,30,32,34,35,38,41,42], but
none reported any harm. Four of these described no adverse
events and suggested that HBT could serve to normalise HIV
testing by its uniform and non-discriminatory deployment
regardless of risk factors or health status [28,30,32,34]. Wolff et
al. presented qualitative research findings that fear of stigmatisa-
tion and emotional vulnerability associated with receiving results
from public facilities were the most common reasons given for the
relative popularity of HBT [34]. A further three articles noted that
concerns about stigma and fears about confidentiality could
A Meta-Analysis of Home-Based HIV Testing
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Figure 1. Flow diagram of study selection process.
doi:10.1371/journal.pmed.1001351.g001
A Meta-Analysis of Home-Based HIV Testing
PLOS Medicine | www.plosmedicine.org 4 December 2012 | Volume 9 | Issue 12 | e1001351
T
a
b
le
1
.
C
h
ar
ac
te
ri
st
ic
s
o
f
in
cl
u
d
e
d
st
u
d
ie
s.
F
ir
st
A
u
th
o
r,
P
u
b
li
ca
ti
o
n
Y
e
a
r
C
o
u
n
tr
y
,
S
e
tt
in
g
P
e
ri
o
d
o
f
S
tu
d
y
N
u
m
b
e
r
O
ff
e
re
d
T
e
st
in
g
P
u
rp
o
se
o
f
S
tu
d
y
H
IV
P
re
v
a
le
n
ce
a
A
g
e
E
li
g
ib
il
it
y
o
f
P
a
rt
ic
ip
a
n
ts
T
e
st
in
g
P
ro
v
id
e
r
C
o
m
m
u
n
it
y
S
e
n
si
ti
sa
ti
o
n
D
e
sc
ri
b
e
d
In
ce
n
ti
v
e
s
P
ro
v
id
e
d
S
a
m
p
li
n
g
M
e
th
o
d
a
n
d
T
e
st
s
U
se
d
P
e
rc
e
n
t
P
re
v
io
u
sl
y
T
e
st
e
d
A
n
g
o
tt
i
(1
),
2
0
0
9
M
al
aw
i,
th
re
e
ru
ra
l
d
is
tr
ic
ts
2
0
0
4
3
,6
5
9
Lo
n
g
it
u
d
in
al
H
IV
p
re
va
le
n
ce
st
u
d
y
4
.4
%
–
7
.9
%
1
5
–
4
9
y
Lo
ca
lly
tr
ai
n
e
d
V
C
T
co
u
n
se
llo
rs
Y
e
s
N
o
O
ra
l
sw
ab
(O
ra
su
re
)
(2
0
0
4
)
N
o
t
sp
e
ci
fi
e
d
A
n
g
o
tt
i
(2
),
2
0
0
9
A
s
ab
o
ve
2
0
0
6
3
,4
5
9
A
s
ab
o
ve
A
s
ab
o
ve
A
s
ab
o
ve
A
s
ab
o
ve
A
s
ab
o
ve
A
s
ab
o
ve
FP
R
D
T
s
(D
e
te
rm
in
e
an
d
U
n
iG
o
ld
)
(2
0
0
6
)
6
6
%
C
h
o
ko
,
2
0
1
1
M
al
aw
i,
u
rb
an
d
is
tr
ic
t
2
0
1
0
2
1
6
Fe
as
ib
ili
ty
o
f
(s
u
p
e
rv
is
e
d
)
o
ra
l
se
lf
-t
e
st
in
g
11
%
2
2
–
3
2
y
Se
lf
-a
d
m
in
is
te
re
d
(s
u
p
e
rv
is
io
n
fr
o
m
V
C
T
co
u
n
se
llo
r)
N
o
N
o
O
ra
l
sw
ab
(O
ra
q
u
ic
k)
fo
llo
w
e
d
b
y
FP
R
D
T
s
(D
e
te
rm
in
e
an
d
U
n
iG
o
ld
)
6
3
%
H
e
lle
ri
n
g
e
r,
2
0
0
9
M
al
aw
i,
ru
ra
l
d
is
tr
ic
t
2
0
0
6
7
5
1
U
p
ta
ke
o
f
H
B
T
11
%
1
8
–
3
5
y
T
ra
in
e
d
h
e
al
th
co
u
n
se
llo
rs
Y
e
s
Y
e
s—
b
ar
o
f
so
ap
FP
R
D
T
s
(D
e
te
rm
in
e
an
d
U
n
iG
o
ld
)
2
1
%
K
im
ai
yo
,
2
0
1
0
K
e
n
ya
,
tw
o
ru
ra
l
d
is
tr
ic
ts
2
0
0
7
–
2
0
0
9
1
0
1
,1
6
7
Fe
as
ib
ili
ty
an
d
ac
ce
p
ta
b
ili
ty
o
f
H
B
T
6.
3%
.
1
3
y
an
d
e
lig
ib
le
ch
ild
re
n
b
C
o
u
n
se
llo
rs
tr
ai
n
ed
fo
r
p
u
rp
o
se
Y
e
s
N
o
FP
R
D
T
s
(D
e
te
rm
in
e
an
d
B
io
lin
e
)
2
6
%
c
K
ra
n
ze
r,
2
0
0
8
M
al
aw
i,
ru
ra
l
d
is
tr
ic
t
2
0
0
5
–
2
0
0
6
2
,0
4
7
Fa
ct
o
rs
as
so
ci
at
e
d
w
it
h
H
B
T
re
fu
sa
l
1
1
.4
%
1
8
–
5
9
y
T
ra
in
e
d
lo
ca
l
V
C
T
co
u
n
se
llo
rs
N
o
N
o
V
e
n
o
u
s
b
lo
o
d
sa
m
p
lin
g
fo
r
EL
IS
A
an
d
p
ar
ti
cl
e
ag
g
lu
ti
n
at
io
n
te
st
in
g
in
la
b
o
ra
to
ry
3
6
%
Lu
g
ad
a,
2
0
1
0
U
g
an
d
a,
fi
ve
ru
ra
l
d
is
tr
ic
ts
2
0
0
5
–
2
0
0
7
4
,7
9
8
U
p
ta
ke
o
f
H
B
T
ve
rs
u
s
cl
in
ic
-b
as
e
d
te
st
in
g
in
h
o
u
se
h
o
ld
m
e
m
b
e
rs
o
f
H
IV
-p
o
si
ti
ve
in
d
e
x
p
at
ie
n
t
5
.6
%
A
n
y
T
ra
in
e
d
la
y
fi
e
ld
w
o
rk
e
rs
N
o
N
o
FP
R
D
T
s
(D
e
te
rm
in
e
sc
re
e
n
in
g
,
U
n
ig
o
ld
co
n
fi
rm
at
io
n
)
N
o
t
sp
e
ci
fi
e
d
M
ah
e
sw
ar
an
,
2
0
1
2
So
u
th
A
fr
ic
a,
ru
ra
l
d
is
tr
ic
t
2
0
0
9
1
,7
2
6
U
p
ta
ke
o
f
H
B
T
an
d
co
m
m
u
n
it
y
m
o
b
ile
H
IV
te
st
in
g
an
d
fa
ct
o
rs
as
so
ci
at
e
d
w
it
h
H
B
T
ve
rs
u
s
m
o
b
ile
te
st
in
g
2
2
%
$
1
5
y
H
IV
C
o
u
n
se
llo
rs
N
o
N
o
N
o
t
sp
e
ci
fi
e
d
d
4
0
%
M
at
o
vu
,
2
0
0
2
U
g
an
d
a,
ru
ra
l
d
is
tr
ic
t
1
9
9
9
–
2
0
0
0
1
1
,7
0
9
U
p
ta
ke
o
f
H
B
T
an
d
e
ff
e
ct
s
o
n
se
xu
al
ri
sk
b
e
h
av
io
u
r
an
d
H
IV
ac
q
u
is
it
io
n
5.
6%
1
5
–
4
9
y
C
o
u
n
se
llo
rs
N
o
N
o
V
e
n
o
u
s
b
lo
o
d
sa
m
p
lin
g
fo
r
EL
IS
A
(6
2
)
te
st
in
g
in
la
b
o
ra
to
ry
5
5
%
M
e
n
zi
e
s,
2
0
0
9
U
g
an
d
a,
se
tt
in
g
n
o
t
sp
e
ci
fi
e
d
2
0
0
3
–
2
0
0
5
4
9
,4
7
0
C
o
m
p
ar
is
o
n
o
f
fo
u
r
te
st
in
g
ap
p
ro
ac
h
e
s:
d
o
o
r-
to
-d
o
o
r
H
B
T
,
h
o
u
se
h
o
ld
m
e
m
b
e
r
(o
f
in
d
e
x
H
IV
p
at
ie
n
t)
ta
rg
e
te
d
H
B
T
,
st
an
d
-a
lo
n
e
,
h
o
sp
it
al
-b
as
e
d
V
C
T
5.
6%
A
n
y
N
o
t
sp
e
ci
fi
e
d
Y
e
s
N
o
FP
R
D
T
s
(s
cr
e
e
n
in
g
te
st
fo
llo
w
e
d
b
y
co
n
fi
rm
at
io
n
if
H
IV
-
p
o
si
ti
ve
;
te
st
s
n
o
t
sp
e
ci
fi
e
d
)
1
0
%
A Meta-Analysis of Home-Based HIV Testing
PLOS Medicine | www.plosmedicine.org 5 December 2012 | Volume 9 | Issue 12 | e1001351
T
a
b
le
1
.
C
o
n
t.
F
ir
st
A
u
th
o
r,
P
u
b
li
ca
ti
o
n
Y
e
a
r
C
o
u
n
tr
y
,
S
e
tt
in
g
P
e
ri
o
d
o
f
S
tu
d
y
N
u
m
b
e
r
O
ff
e
re
d
T
e
st
in
g
P
u
rp
o
se
o
f
S
tu
d
y
H
IV
P
re
v
a
le
n
ce
a
A
g
e
E
li
g
ib
il
it
y
o
f
P
a
rt
ic
ip
a
n
ts
T
e
st
in
g
P
ro
v
id
e
r
C
o
m
m
u
n
it
y
S
e
n
si
ti
sa
ti
o
n
D
e
sc
ri
b
e
d
In
ce
n
ti
v
e
s
P
ro
v
id
e
d
S
a
m
p
li
n
g
M
e
th
o
d
a
n
d
T
e
st
s
U
se
d
P
e
rc
e
n
t
P
re
v
io
u
sl
y
T
e
st
e
d
M
ic
h
e
lo
,
2
0
0
6
Z
am
b
ia
,
o
n
e
ru
ra
l,
o
n
e
u
rb
an
d
is
tr
ic
t
2
0
0
3
5
,4
4
5
H
IV
p
re
va
le
n
ce
su
rv
e
y
20
.4
%
1
5
–
5
9
y
N
o
t
sp
e
ci
fi
e
d
N
o
N
o
B
io
n
o
r
sa
liv
a
te
st
an
d
‘‘s
e
ru
m
te
st
’’
fo
r
sa
liv
a-
p
o
si
ti
ve
o
r
se
co
n
d
sa
liv
a
te
st
N
o
t
sp
e
ci
fi
e
d
M
o
le
sw
o
rt
h
,
2
0
1
0
M
al
aw
i,
ru
ra
l
d
is
tr
ic
t
2
0
0
7
–
2
0
0
8
1
6
,8
9
4
T
o
as
se
ss
th
e
p
e
rf
o
rm
an
ce
o
f
H
IV
R
D
T
s
in
a
H
IV
p
re
va
le
n
ce
su
rv
e
y
1
1
.6
%
$
1
5
y
N
o
n
-l
ab
o
ra
to
ry
b
as
ic
h
e
al
th
p
e
rs
o
n
n
e
l
Y
e
s
N
o
V
e
n
o
u
s
b
lo
o
d
sa
m
p
lin
g
fo
r
R
D
T
s
(D
e
te
rm
in
e
an
d
U
n
ig
o
ld
in
p
ar
al
le
l
p
re
-M
ay
2
0
0
8
,
se
ri
al
ly
p
o
st
-M
ay
2
0
0
8
)
N
o
t
sp
e
ci
fi
e
d
N
e
g
in
,
2
0
0
9
K
e
n
ya
,
ru
ra
l
p
ro
vi
n
ce
2
0
0
8
2
,0
3
3
Fe
as
ib
ili
ty
,
ac
ce
p
ta
b
ili
ty
,
an
d
co
st
o
f
H
B
T
7
.8
%
1
5
–
4
9
y
La
y
co
u
n
se
llo
rs
Y
e
s
N
o
FP
R
D
T
s
(D
e
te
rm
in
e
an
d
B
io
lin
e
)
N
o
t
sp
e
ci
fi
e
d
Se
ka
n
d
ie
,
2
0
1
1
U
g
an
d
a,
u
rb
an
d
is
tr
ic
t
2
0
0
9
5
8
8
U
p
ta
ke
o
f
H
B
T
an
d
fa
ct
o
rs
as
so
ci
at
e
d
w
it
h
H
B
T
6.
5%
$
1
5
y
T
ra
in
e
d
n
u
rs
e
co
u
n
se
llo
rs
N
o
N
o
FP
R
D
T
s
(D
e
te
rm
in
e
sc
re
e
n
in
g
,
St
at
p
ak
co
n
fi
rm
at
io
n
)
6
1
%
Sh
is
an
a,
2
0
0
4
So
u
th
A
fr
ic
a,
n
at
io
n
w
id
e
2
0
0
2
9
,9
6
3
H
IV
p
re
va
le
n
ce
su
rv
e
y
26
.5
%
$
2
y
N
u
rs
e
s
N
o
Y
e
s—
m
o
n
e
y
p
ro
vi
d
e
d
to
h
e
ad
o
f
h
o
u
se
h
o
ld
FP
o
n
to
fi
lt
e
r
p
ap
e
r;
EL
IS
A
(6
2
)
te
st
in
g
in
la
b
o
ra
to
ry
N
o
t
sp
e
ci
fi
e
d
T
u
m
w
e
si
g
ye
,
2
0
1
0
U
g
an
d
a,
ru
ra
l
d
is
tr
ic
t
2
0
0
4
–
2
0
0
7
2
8
2
,8
5
7
A
cc
e
p
ta
b
ili
ty
an
d
u
p
ta
ke
o
f
H
B
T
5.
4%
.
1
4
y
an
d
e
lig
ib
le
ch
ild
re
n
.
1
8
m
o
f
C
o
u
n
se
llo
r
an
d
la
b
o
ra
to
ry
as
si
st
an
t
te
am
s
Y
e
s
Y
e
s—
H
IV
-
p
o
si
ti
ve
p
ro
vi
d
e
d
w
it
h
co
n
d
o
m
s,
in
se
ct
ic
id
e
-
tr
e
at
e
d
b
e
d
n
e
ts
,
an
d
h
o
m
e
w
at
e
r
tr
e
at
m
e
n
t
e
q
u
ip
m
e
n
t
FP
R
D
T
s
(D
e
te
rm
in
e
sc
re
e
n
in
g
,
St
at
p
ak
co
n
fi
rm
at
io
n
)
9
%
W
e
lz
(1
),
2
0
0
7
So
u
th
A
fr
ic
a,
ru
ra
l
d
is
tr
ic
t
2
0
0
3
–
2
0
0
4
1
9
,8
6
7
H
IV
p
re
va
le
n
ce
su
rv
e
y
(r
e
si
d
e
n
ts
)
27
.9
%
W
o
m
e
n
1
5
–
4
9
y;
m
e
n
1
5
–
5
4
y
T
ra
in
e
d
fi
e
ld
w
o
rk
e
rs
N
o
N
o
FP
o
n
to
fi
lt
e
r
p
ap
e
r;
EL
IS
A
(6
2
)
te
st
in
g
in
la
b
o
ra
to
ry
N
o
t
sp
e
ci
fi
e
d
W
e
lz
(2
),
2
0
0
7
A
s
ab
o
ve
A
s
ab
o
ve
9
1
6
H
IV
p
re
va
le
n
ce
su
rv
e
y
(s
u
b
se
t
o
f
m
ig
ra
n
ts
in
th
e
co
m
m
u
n
it
y)
A
s
ab
o
ve
A
s
ab
o
ve
A
s
ab
o
ve
N
o
N
o
A
s
ab
o
ve
N
o
t
sp
e
ci
fi
e
d
A Meta-Analysis of Home-Based HIV Testing
PLOS Medicine | www.plosmedicine.org 6 December 2012 | Volume 9 | Issue 12 | e1001351
T
a
b
le
1
.
C
o
n
t.
F
ir
st
A
u
th
o
r,
P
u
b
li
ca
ti
o
n
Y
e
a
r
C
o
u
n
tr
y
,
S
e
tt
in
g
P
e
ri
o
d
o
f
S
tu
d
y
N
u
m
b
e
r
O
ff
e
re
d
T
e
st
in
g
P
u
rp
o
se
o
f
S
tu
d
y
H
IV
P
re
v
a
le
n
ce
a
A
g
e
E
li
g
ib
il
it
y
o
f
P
a
rt
ic
ip
a
n
ts
T
e
st
in
g
P
ro
v
id
e
r
C
o
m
m
u
n
it
y
S
e
n
si
ti
sa
ti
o
n
D
e
sc
ri
b
e
d
In
ce
n
ti
v
e
s
P
ro
v
id
e
d
S
a
m
p
li
n
g
M
e
th
o
d
a
n
d
T
e
st
s
U
se
d
P
e
rc
e
n
t
P
re
v
io
u
sl
y
T
e
st
e
d
W
e
re
,
2
0
0
3
U
g
an
d
a,
ru
ra
l
d
is
tr
ic
t
N
o
t
sp
e
ci
fi
e
d
2
,3
7
3
U
p
ta
ke
o
f
V
C
T
an
d
H
B
T
4.
1%
A
n
y
N
o
t
sp
e
ci
fi
e
d
N
o
N
o
V
e
n
o
u
s
sa
m
p
lin
g
,
te
st
s
n
o
t
sp
e
ci
fi
e
d
N
o
t
sp
e
ci
fi
e
d
W
e
re
,
2
0
0
6
U
g
an
d
a,
tw
o
ru
ra
l
d
is
tr
ic
ts
2
0
0
3
–
2
0
0
4
3
,3
3
8
H
IV
p
re
va
le
n
ce
an
d
ac
ce
p
ta
b
ili
ty
o
f
H
B
T
am
o
n
g
h
o
u
se
h
o
ld
m
e
m
b
e
rs
o
f
H
IV
-
p
o
si
ti
ve
in
d
e
x
p
at
ie
n
t
4.
1%
A
n
y
C
o
u
n
se
llo
rs
N
o
N
o
FP
o
n
to
fi
lt
e
r
p
ap
e
r;
EL
IS
A
(6
2
)
te
st
in
g
in
la
b
o
ra
to
ry
;
fo
r
ch
ild
re
n
,
2
4
m
o
,
H
IV
D
N
A
m
e
as
u
re
m
e
n
t
o
n
d
ri
e
d
b
lo
o
d
sp
o
t
4
.9
%
W
o
lf
fg
,
2
0
0
5
U
g
an
d
a,
ru
ra
l
(1
5
vi
lla
g
e
s)
2
0
0
1
1
,5
9
1
U
p
ta
ke
o
f
H
IV
re
su
lt
s
fr
o
m
H
IV
p
re
va
le
n
ce
su
rv
e
y
7.
9%
$
1
5
y
C
o
u
n
se
llo
rs
N
o
N
o
V
en
o
u
s
b
lo
o
d
sa
m
p
lin
g
fo
r
EL
IS
A
(6
2
)
te
st
in
g
in
la
b
o
ra
to
ry
N
o
t
sp
e
ci
fi
e
d
a
D
at
a
fr
o
m
st
u
d
y
ar
e
a,
o
r
Jo
in
t
U
n
it
e
d
N
at
io
n
s
P
ro
g
ra
m
m
e
o
n
H
IV
/A
ID
S
n
at
io
n
al
d
at
a
(a
d
u
lt
p
re
va
le
n
ce
)
if
sh
o
w
n
in
it
al
ic
s.
b
El
ig
ib
le
if
,
1
3
y
an
d
m
o
th
e
r
H
IV
-p
o
si
ti
ve
,
m
o
th
e
r
H
IV
st
at
u
s
u
n
kn
o
w
n
,
o
r
m
o
th
e
r
d
e
ad
.
c
3
5
,8
1
5
/1
3
7
,2
6
8
e
n
co
u
n
te
re
d
in
th
e
ar
e
a.
d
St
at
e
d
o
n
ly
as
fo
llo
w
in
g
n
at
io
n
al
g
u
id
e
lin
e
s
fo
r
te
st
in
g
.
e
Ex
cl
u
d
e
d
n
o
n
-E
n
g
lis
h
an
d
n
o
n
-L
u
g
an
d
an
sp
e
ak
e
rs
.
f E
lig
ib
le
if
m
o
th
e
r
d
e
ce
as
e
d
o
r
H
IV
-p
o
si
ti
ve
.
g
St
u
d
y
d
o
n
e
in
p
e
ri
o
d
b
e
fo
re
an
ti
re
tr
o
vi
ra
ls
w
e
re
av
ai
la
b
le
.
EL
IS
A
,
e
n
zy
m
e
-l
in
ke
d
im
m
u
n
o
so
rb
e
n
t
as
sa
y;
FP
,
fi
n
g
e
r
p
ri
ck
;
R
D
T
,
ra
p
id
d
ia
g
n
o
st
ic
te
st
;
V
C
T
,
vo
lu
n
ta
ry
co
u
n
se
lli
n
g
an
d
te
st
in
g
.
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
m
e
d
.1
0
0
1
3
5
1
.t
0
0
1
A Meta-Analysis of Home-Based HIV Testing
PLOS Medicine | www.plosmedicine.org 7 December 2012 | Volume 9 | Issue 12 | e1001351
T
a
b
le
2
.
A
ss
e
ss
m
e
n
t
o
f
st
u
d
y
ri
g
o
u
r.
F
ir
st
A
u
th
o
r,
P
u
b
li
ca
ti
o
n
Y
e
a
r
S
tu
d
y
P
ro
ce
ss
Q
u
a
li
ty
In
d
ic
a
to
rs
R
e
se
a
rc
h
M
e
th
o
d
Q
u
a
li
ty
In
d
ic
a
to
rs
P
re
-T
e
st
C
o
u
n
se
ll
in
g
D
o
n
e
a
C
o
n
se
n
t
P
ro
v
id
e
d
T
e
st
O
ff
e
re
d
w
it
h
th
e
In
te
n
ti
o
n
o
f
G
iv
in
g
R
e
su
lt
s
to
C
li
e
n
ts
b
C
o
n
fi
rm
a
to
ry
L
a
b
o
ra
to
ry
T
e
st
in
g
D
o
n
e
D
is
co
rd
a
n
t
R
e
su
lt
s
A
d
d
re
ss
e
d
a
R
e
p
e
a
t
S
a
m
p
li
n
g
if
D
is
co
rd
a
n
t
R
e
p
e
a
t
V
is
it
s
if
A
b
se
n
te
e
is
m
S
p
e
ci
fi
c
A
d
v
ic
e
if
H
IV
R
e
su
lt
N
e
g
a
ti
v
e
L
in
k
a
g
e
to
C
a
re
fo
r
H
IV
-I
n
fe
ct
e
d
S
a
m
p
li
n
g
S
tr
a
te
g
y
D
e
sc
ri
b
e
d
S
e
le
ct
iv
e
O
u
tc
o
m
e
R
e
p
o
rt
in
g
A
n
g
o
tt
i,
2
0
0
9
Y
e
s
Y
e
s
Y
e
s
N
o
N
o
t
sp
e
ci
fi
e
d
N
o
N
o
Y
e
s—
re
te
st
in
3
m
o
ti
m
e
Y
e
s
Y
e
s
N
o
C
h
o
ko
,
2
0
1
1
Y
e
s
Y
e
s
N
o
N
o
Y
e
s
Y
e
s
N
o
N
o
Y
e
s
Y
e
s
N
o
H
e
lle
ri
n
g
e
r,
2
0
0
9
Y
e
s
Y
e
s
N
o
N
o
N
o
t
sp
e
ci
fi
e
d
Y
e
s
Y
e
s
N
o
N
o
Y
e
s
N
o
K
im
ai
yo
,
2
0
1
0
Y
e
s
Y
e
s
Y
e
s
N
o
Y
e
s
Y
e
s
Y
e
s
Y
e
s—
b
e
h
av
io
u
r
ch
an
g
e
an
d
‘‘A
B
C
s’
’
o
f
H
IV
p
re
ve
n
ti
o
n
Y
e
s
N
o
N
o
K
ra
n
ze
r,
2
0
0
8
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
N
o
N
o
Y
e
s
N
o
Lu
g
ad
a,
2
0
1
0
Y
e
s
Y
e
s
Y
e
s
N
o
Y
e
s
Y
e
s
Y
e
s
N
o
Y
e
s
Y
e
s
N
o
M
ah
e
sw
ar
an
,
2
0
1
2
Y
e
s
Y
e
s
Y
e
s
N
o
N
o
t
sp
e
ci
fi
e
d
N
o
N
o
N
o
Y
e
s
N
o
N
o
M
at
o
vu
,
2
0
0
2
Y
e
s
Y
e
s
N
o
Y
e
s
Y
e
s
Y
e
s
Y
e
s
N
o
N
o
N
o
N
o
M
e
n
zi
e
s,
2
0
0
9
Y
e
s
Y
e
s
Y
e
s
Y
e
s
N
o
t
sp
e
ci
fi
e
d
Y
e
s
N
o
N
o
Y
e
s
N
o
N
o
M
ic
h
e
lo
,
2
0
0
6
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
N
o
N
o
N
o
Y
e
s
N
o
M
o
le
sw
o
rt
h
,
2
0
1
0
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
N
o
N
o
Y
e
s
Y
e
s
N
o
N
e
g
in
,
2
0
0
9
Y
e
s
Y
e
s
Y
e
s
N
o
Y
e
s
Y
e
s
N
o
N
o
Y
e
s
N
o
N
o
Se
ka
n
d
i,
2
0
1
1
Y
e
s
Y
e
s
Y
e
s
N
o
Y
e
s
Y
e
s
N
o
Y
e
s—
H
IV
p
re
ve
n
ti
o
n
co
u
n
se
lli
n
g
Y
e
s
Y
e
s
N
o
Sh
is
an
a,
2
0
0
4
N
o
t
sp
e
ci
fi
e
d
Y
e
s
N
o
Y
e
s
N
o
t
sp
e
ci
fi
e
d
Y
e
s
Y
e
s
N
o
N
o
Y
e
s
N
o
T
u
m
w
e
si
g
ye
,
2
0
1
0
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
N
o
N
o
Y
e
s
N
o
N
o
W
e
lz
,
2
0
0
7
N
o
t
sp
e
ci
fi
e
d
Y
e
s
Y
e
s
Y
e
s
N
o
t
sp
e
ci
fi
e
d
Y
e
s
Y
e
s
N
o
N
o
Y
e
s
N
o
W
e
re
,
2
0
0
3
Y
e
s
Y
e
s
N
o
N
o
N
o
t
sp
e
ci
fi
e
d
N
o
Y
e
s
N
o
N
o
N
o
N
o
W
e
re
,
2
0
0
6
N
o
t
sp
e
ci
fi
e
d
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
N
o
N
o
N
o
N
o
N
o
W
o
lf
f,
2
0
0
5
N
o
t
sp
e
ci
fi
e
d
Y
e
s
N
o
Y
e
s
Y
e
s
Y
e
s
N
o
N
o
N
o
Y
e
s
N
o
a
W
h
e
re
n
o
in
fo
rm
at
io
n
is
av
ai
la
b
le
‘‘n
o
t
sp
e
ci
fi
e
d
’’
is
in
d
ic
at
e
d
fo
r
th
e
se
va
ri
ab
le
s,
as
w
e
co
n
si
d
e
re
d
it
p
o
ss
ib
le
th
at
th
e
se
ac
ti
vi
ti
e
s
w
e
re
d
o
n
e
b
u
t
n
o
t
re
p
o
rt
e
d
in
th
e
p
ap
e
r.
b
So
m
e
st
u
d
ie
s
o
ff
e
re
d
te
st
in
g
b
u
t
re
su
lt
s
w
e
re
n
o
t
p
ro
m
is
e
d
,
e
.g
.,
re
su
lt
s
av
ai
la
b
le
o
n
ly
if
cl
ie
n
t
so
u
g
h
t
th
e
re
su
lt
se
p
ar
at
e
ly
;
so
m
e
st
u
d
ie
s
w
e
re
e
n
ti
re
ly
b
lin
d
e
d
,
e
.g
.,
w
h
e
re
te
st
in
g
w
as
d
o
n
e
fo
r
an
o
n
ym
o
u
s
p
o
p
u
la
ti
o
n
H
IV
p
re
va
le
n
ce
e
st
im
at
io
n
.
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
m
e
d
.1
0
0
1
3
5
1
.t
0
0
2
A Meta-Analysis of Home-Based HIV Testing
PLOS Medicine | www.plosmedicine.org 8 December 2012 | Volume 9 | Issue 12 | e1001351
account for non-participation in HBT [38,41,42]; uptake in these
studies was 71%–98%. Another study commented that confiden-
tiality may be enhanced with HBT [35]. Two studies (both from
Uganda) reported on the costs of HBT and demonstrated that the
cost of testing per client was less than US$9 [30,32].
Heterogeneity
The studies were conducted in a range of countries, settings,
and contexts (of HIV awareness and treatment availability). There
were 14 studies examining the feasibility, acceptability, and uptake
of HBT as an approach to testing; six studies were carried out to
estimate HIV prevalence and utilised HBT as the approach in
their surveys; and one study was done to assess the performance of
rapid tests for HIV in the context of an HIV prevalence survey.
Statistical heterogeneity was also high; however, over three-
quarters of the studies (16/21 studies; n=449,970) reported an
acceptance rate above 70%. Sub-group analyses to examine
heterogeneity did not find any statistically significant differences in
HBT uptake and receipt of results according to study period, study
setting, or whether sensitisation campaigns were reported as being
done (Figure 4). The provision of incentives appeared to result in
higher test uptake. Studies in which,30% of individuals had been
previously tested, in sites where local HIV prevalence was ,10%,
or where HBT was offered to household members of HIV-positive
individuals also had higher uptake of testing (Figure 4).There was
also a tendency towards a greater frequency of test acceptance
when immediate provision of results was available, although this
finding was not statistically significant (86.5% [95% CI: 82.9%–
92.0%] versus 79.2% [95% CI: 70.7%–87.7%], p=0.1).
Discussion
This systematic review and meta-analysis of 19 papers based on
21 studies of HBT across five countries in SSA demonstrates that
voluntary counselling and testing for HIV at home is highly
acceptable. While pooled estimates derived from heterogenous
Figure 2. Proportion accepting HBT.
doi:10.1371/journal.pmed.1001351.g002
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studies should be interpreted with caution, an average 83% of
people accepted testing, and 99% of those accepting testing
received their result. Over three-quarters of everyone who was
offered a test accepted to be tested and received their result (77%
in 16 studies reporting on this). The proportion of previously
undiagnosed HIV was high (40%–79% of those diagnosed HIV-
positive), emphasising the value of HBT.
It is acknowledged that means of increasing access to testing are
needed in order to achieve universal knowledge of HIV status [5].
A study from Malawi of clinic-based HIV counselling and testing
showed that just 13.3% of 18,021 clinic attendances (8.5%
amongst men) included HIV counselling and testing [45]. Recent
studies have suggested that there is high willingness to participate
in HBT, and the proportion of individuals ever tested for HIV in a
community in Uganda rose from 19% to 62% following an HBT
campaign [6,46]. This meta-analysis confirms that HBT is an
important approach to improve awareness of HIV status in SSA,
and it can be used in addition to other approaches such as stand-
alone testing, community and work-place testing, and provider-
initiated testing.
Delayed presentation for HIV treatment services is recognised
as an important cause of morbidity and mortality from HIV
despite major progress in increasing access to antiretrovirals [47].
Both studies that reported on the clinical status of patients
diagnosed HIV-positive upon HBT found that the majority had
CD4 counts above treatment initiation thresholds (for the study
period) [30,32]. Tumwesigye et al. found that of the HIV-positive
individuals tested for CD4 count, 45% had CD4 count .350
cells/mm3 (and 68% .200 cells/mm3) [32]. Similarly, Menzies
et al. found that 69% of HIV-positive individuals identified
through HBT had CD4 count .200 cells/mm3. In this latter
study, which compared approaches of HIV testing, the propor-
tions of HIV-positive individuals identified with a CD4 count
,50 cells/mm3 through stand-alone voluntary counselling and
testing and hospital-based testing were 20% and 24%, respec-
tively, while the corresponding proportion was 12% for HBT
targeted to household members of known HIV-positive individ-
uals, and 6% for untargeted HBT [30]. This is consistent with
other findings that suggest HBT is a useful approach for earlier
detection of HIV, initiation of treatment, and better prognosis
[13,48], as well as for higher impact with treatment as prevention
[49,50]. A recent pilot study in South Africa found a reduction in
mean community viral load 6 mo after the introduction of a HBT
campaign [51].
Figure 3. Proportion achieving knowledge of HIV status overall.
doi:10.1371/journal.pmed.1001351.g003
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While women are disproportionately affected by HIV in SSA
[5], men have long been known to under-utilise HIV services and
to present later for care than women, and consequently they have
worse outcomes on treatment [45,52,53]. In the studies reviewed
here, an overall proportion of 47% of those offered testing were
men. This compares favourably with facility-based testing, where
testing of males attending the clinic may be as low as 9% [45]. In
our meta-analysis of HBT, an almost equivalent proportion of
men were offered a test as women, and they were as likely to
accept testing, an outcome that gives promise of greatly improving
awareness of HIV status for both sexes. Studies that provided
results at a distant site even if testing was conducted at home were
associated with lower proportions of people receiving results out of
those who accepted testing. While this emphasises the benefits of
HBT including immediate provision of results in raising awareness
of HIV status, it may be of less concern given that rapid diagnostic
tests with immediate results are now the norm for voluntary HIV
testing globally.
Examination of trends by country suggest lower uptake of
testing in South Africa, where three out of five studies reported
uptake of #70% (note that two of these studies were in the same
setting in KwaZulu-Natal) (Figure 1) [27,38]. However, the most
recent study from South Africa found very high uptake of HBT
(91.8%) [44]. Based on the paucity of countries and the number of
studies per country available for this review, it would be unwise to
draw conclusions about country differences and acceptability of
HBT.
While the results of sub-group analyses need to be interpreted
with caution, they suggest that the running of pre-test sensitisation
campaigns may be of little benefit in terms of uptake of HBT.
However, these are essentially ‘‘ecological’’ comparisons, which
may be confounded by many other differences between the study
populations examined. Also, the number of studies where
incentives were given was very small (Table 1), and strong
conclusions cannot be drawn. Nevertheless, the fact that most of
the studies demonstrated similar proportions of uptake of HBT
perhaps argues against a strong effect. The finding that studies
with a lower proportion of individuals previously tested for HIV
(,30%) had a higher frequency of test uptake points to the value
of HBT as an effective approach to engage those not previously
aware of their HIV status in testing. It could suggest that HBT is
effective in achieving initial diagnosis but less so for repeat testing.
Targeted HBT of index HIV-positive clients’ household members
may be an effective way to achieve higher acceptance in settings
Figure 4. Sub-group analyses.
doi:10.1371/journal.pmed.1001351.g004
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where more general HBT is not feasible because of resource
limitations.
Uptake of HBT may be influenced by availability of treatment,
as indicated by the fact that the study with the lowest overall
success (only 25% of people offered a test received their result) was
done at a time when antiretroviral treatment was not available in
the communities studied [34] (although overall there was no effect
of ‘‘study period’’). However, there may be other confounding
factors involved, and this study was based on a small sample size;
in sensitivity analysis, excluding it from the analysis did not change
the pooled estimate of uptake of HBT (data not shown). Three
other studies were notable for having ,70% receipt of results
amongst those who accepted HBT (Figure S1). Two of these
studies offered the option of receiving results at a later date
[26,29], while the third [28] offered the option of receiving results
on the same day.
Human rights protections should be an integral part of any
testing campaign, and every effort should be made to avoid
physical, social, and psychological harm to individuals [16,17].
However, the high level of uptake we have found overall seems to
indicate acceptability of HBT in the communities studied.
There are several strengths and limitations to this review. We
used a broad search strategy that allowed us to capture 21 studies
(published in 19 articles), resulting in a large overall sample size
and giving increased confidence in the pooled estimates. There
was high statistical heterogeneity, as expected for pooled
proportions in observational studies. We limited our search to
studies conducted in SSA over the last decade in order to improve
comparability, and used a random-effects model to pool data. We
undertook a number of sensitivity and sub-group analyses to
explore potential sources of heterogeneity. The non-uniformity of
the studies, which were nonetheless looking at uptake of a
‘‘uniform’’ activity (the offer of an HIV test at home), could be
considered both a strength and limitation of our review. While it
may be a limitation for pooling results, it could be considered a
strength that even in a range of study contexts, HBT consistently
achieved higher uptake than is seen in facility-based testing.
Another limitation was that, as a trade-off to using a broad
search strategy, our search was limited to just three databases and
to published articles in peer-reviewed journals. We therefore
cannot rule out the possibility that we may have missed some
studies, or the possibility of publication bias leading to the non-
publication of studies with lower uptake. The limited number of
studies that provided data on the health status of those identified as
HIV-positive by HBT is a further shortcoming that this review was
unable to address. Our findings do, however, indicate a number of
directions for future research. In particular, key areas for research
include linkage to care following HBT, retention in care of those
identified HIV-positive through HBT (who are more likely to be
clinically well when diagnosed), as well as repeated HBT for
ongoing knowledge of HIV status. The option of self-testing with
support from HBT staff is an area of research that is highly topical
given recent developments in self-testing [54]. The suggestion from
this review that the conduct of sensitisation campaigns has little or
no impact on uptake of HBT and receipt of results has important
implications for programme cost and efficiency and deserves
further evaluation. More data are needed on the effectiveness of
HBT in detecting previously undiagnosed HIV infection. Sustain-
ability and cost considerations (short- and long-term) are
important to help guide policy, and further work on cost-
effectiveness is required. Further research on individual-level
factors associated with participation in HBT, such as that recently
published by Cherutich et al. [6], would inform implementers on
individuals who require further engagement to encourage uptake.
A key finding of our review is that HBT is able to reach wide
sections of communities in a diverse range of contexts and settings.
HBT provides the opportunity to acquire knowledge of HIV status
at the doorstep for those who may not otherwise have sought
testing, and may be pivotal in providing an effective tool for
governments and health service providers to increase access to
HIV treatment and prevention, by increasing uptake of testing.
We conclude that HBT has the potential to dramatically increase
awareness of HIV status in previously undiagnosed men and
women in SSA. HBT is a gateway to accessing care early, and the
benefits for individual and public health, both for treatment and
prevention, make it an invaluable tool in the fight against HIV.
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Editors’ Summary
Background. Knowledge of HIV status is crucial for both
the prevention and treatment of HIV. However, according to
the Joint United Nations Programme on HIV/AIDS (the UN
agency responsible for HIV/AIDS), in low-and-middle-income
countries only ten percent of those who need voluntary
counseling and testing, because they may have been
exposed to HIV infection, have access to this service. Even
in health care settings in which voluntary counseling and HIV
testing is routinely offered, such as to pregnant women, the
number of people who use these services is low. This
situation is partly because of the stigma and discrimination
associated with HIV, which makes people reluctant to
volunteer to come forward to be tested for HIV. To help
overcome this problem, one important strategy in encour-
aging people to be tested for HIV is to offer them the
opportunity to be counseled and tested at home—home-
based voluntary counseling and testing (HBT). Using the HBT
approach, people are visited in their home by health workers
regardless of their perceived risk of HIV. HBT has obvious
advantages and upholds the ‘‘3 Cs’’ principles of HIV testing:
that testing is confidential, accompanied by counseling, and
conducted only with informed consent.
Why Was This Study Done? The HBT approach has
received widespread international support, and the World
Health Organization has recently published guidance to
service providers and policy makers about the delivery of
HBT. However, the acceptability of HBT, that is, whether
those offered HBT actually take up the offer and are tested,
remains unknown, especially in sub-Saharan Africa, the world
region with the highest prevalence of HIV. So, in this study,
the researchers systematically compiled all of the available
studies on this topic from sub-Saharan Africa to determine
the acceptability of HBT and also to and identify any factors
associated with the uptake of HBT.
What Did the Researchers Do and Find? The researchers
searched several databases to identify suitable peer-
reviewed studies from Africa published between January
2000 and September 2012. The researchers included studies
that described any intervention to provide HIV testing at
home and also reported the proportions of participants
accepting HIV testing out of all individuals offered a home-
based HIV test. Because different types of studies were
included (such as randomized controlled trials, observational
cohort studies, and cross-sectional surveys), the researchers
tested the quality of included studies. Then they pooled all
of the studies together to calculate the overall proportion of
people who accepted HIV testing at home and the
proportion who received their result.
Using these methods, the researchers included 21 studies
from five African countries: Kenya, Malawi, South Africa,
Uganda, and Zambia, comprising a total of 524,867 people.
Overall, the proportion of people who accepted HBT ranged
from 58.1% to 99.7%, with a pooled proportion of 83.3%
accepting HBT (474,377 people). In the eight studies that
separated data by gender, men were as likely as women to
accept testing (78.5% versus 81.5%). Over three-quarters of
everyone who accepted HBT received their result (77% in 16
studies reporting on this), and, importantly, the proportion
of people with previously undiagnosed HIV was high (40%–
79% of those diagnosed HIV-positive), emphasizing the value
of HBT. The researchers also found that providing incentives,
local HIV prevalence being less than 10%, and targeting HBT
to household members of HIV-positive individuals may be
factors associated with increased uptake of HBT, but further
research is needed to verify the results of this subgroup
analysis.
What Do These Findings Mean? These findings suggest
that voluntary counseling and testing for HIV at home is
highly acceptable in five countries in sub-Saharan Africa,
with the majority of those tested receiving their test result,
highlighting the importance of this approach in the
diagnosis of HIV. Therefore, by increasing uptake of testing,
HBT may provide an effective tool for governments and
health service providers to increase access to HIV treatment
and prevention. However, testing is just the first step in the
management of HIV, and this study does not address the
follow-up of those who tested positive using the home-
based approach, such as access to treatment, as well as
repeated HBT for ongoing knowledge of HIV status. The
option of self-testing was examined in only one of the
studies included in this review, but the researchers identify
that self-testing at home with the support HBT staff is an
important area of future research. Overall, HBT has the
potential to substantially increase awareness of HIV status in
previously undiagnosed men and women in sub-Saharan
Africa.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001351.
N The World Health Organization provides extensive infor-
mation on HIV testing and counseling, and the World
Health Organization’s guidance on home-based testing
mentioned in this summary is also available
N The Joint United Nations Programme on HIV/AIDS gives
the latest facts and figures about the global status of HIV
and about reducing stigma and discrimination around HIV
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